Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SYLVEN C' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 111 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tyni-Lenne, R; Dencker, K; Gordon, A; Jansson, E; Sylven, C
      Comprehensive local muscle training increases aerobic working capacity andquality of life and decreases neurohormonal activation in patients with chronic heart failure

      EUROPEAN JOURNAL OF HEART FAILURE
    2. Sadigh-Lindell, B; Sylven, C; Hagerman, I; Berglund, M; Terenius, L; Franzen, O; Eriksson, BE
      Oscillation of pain intensity during adenosine infusion. Relationship to beta-endorphin and sympathetic tone

      NEUROREPORT
    3. Sylven, C; Sarkar, N; Ruck, A; Drvota, V; Y-Hassan, S; Lind, B; Nygren, A; Kallner, G; Blomberg, P; van der Linden, J; Lindblom, D; Brodin, LA; Islam, KB
      Myocardial Doppler tissue velocity improves following myocardial gene therapy with VEGF-A(165) plasmid in patients with inoperable angina pectoris

      CORONARY ARTERY DISEASE
    4. Sarkar, N; Ruck, A; Kallner, G; Y-Hassan, S; Blomberg, P; Islam, KB; Van Der Linden, J; Lindblom, D; Nygren, AT; Lind, B; Brodin, LA; Drvota, V; Sylven, C
      Effects of intramyocardial injection of phVEGF-A(165) as sole therapy in patients with refractory coronary artery disease - 12-month follow-up: Angiogenic gene therapy

      JOURNAL OF INTERNAL MEDICINE
    5. Sylven, C; Sarkar, N; Wardell, E; Jamsa, A; Drvota, V; Blomberg, P; Bin Islam, K
      Protein and angiogenic dose-response expression of phVEGF-A(165) gene in rat myocardium

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    6. Jensen, J; Brodin, LA; Lind, B; Eriksson, SV; Jensen-Urstad, M; Sylven, C
      Deterioration in peak systolic velocity is closely related to ischaemia during angioplasty: a vectorcardiographic and tissue Doppler imaging study

      CLINICAL SCIENCE
    7. Gustafsson, T; Bodin, K; Sylven, C; Gordon, A; Tyni-Lenne, R; Jansson, E
      Increased expression of VEGF following exercise training in patients with heart failure

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    8. Collinson, PO; Jorgensen, B; Sylven, C; Haass, M; Chwallek, F; Katus, HA; Muller-Bardorff, M; Derhaschnig, U; Hirschl, MM; Zerback, R
      Recalibration of the point-of-care test for CARDIAC T Quantitative with Elecsys Troponin T 3rd generation

      CLINICA CHIMICA ACTA
    9. Muller-Bardorff, M; Sylven, C; Rasmanis, G; Jorgensen, B; Collinson, PO; Waldenhofer, U; Hirschl, MM; Laggner, AN; Gerhardt, W; Hafner, G; Labaere, I; Leinberger, R; Zerback, R; Katus, HA
      Evaluation of a point-of-care system for quantitative determination of troponin T and myoglobin

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    10. Hellgren, I; Drvota, V; Pieper, R; Enoksson, S; Blomberg, P; Islam, KB; Sylven, C
      Highly efficient cell-mediated gene transfer using non-viral vectors and FuGene (TM) 6: in vitro and in vivo studies

      CELLULAR AND MOLECULAR LIFE SCIENCES
    11. Hellgren, I; Mustafa, A; Riazi, M; Suliman, I; Sylven, C; Adem, A
      Muscarinic M-3 receptor subtype gene expression in the human heart

      CELLULAR AND MOLECULAR LIFE SCIENCES
    12. Jensen, J; Eriksson, SV; Lindvall, B; Lundin, P; Sylven, C
      Women react with more myocardial ischemia and angina pectoris during elective percutaneous transluminal coronary angioplasty

      CORONARY ARTERY DISEASE
    13. Jensen, J; Eriksson, SV; Lindvall, B; Lundin, P; Sylven, C
      On-line vectorcardiography during elective coronary angioplasty indicates procedure-related myocardial infarction

      CORONARY ARTERY DISEASE
    14. Rasmanis, G; Sylven, C
      Tirofiban counteracts pending myocardial infarction

      JOURNAL OF INTERNAL MEDICINE
    15. Hellgren, I; Sylven, C; Magnusson, Y
      Study of the beta(1) adrenergic receptor expression in human tissues: Immunological approach

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    16. Eriksson, BE; Tyni-Lenne, R; Svedenhag, J; Hallin, R; Jensen-Urstad, K; Jensen-Urstad, M; Bergman, K; Sylven, C
      Physical training in Syndrome X - Physical training counteracts deconditioning and pain in Syndrome X

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    17. Cederholm, T; Sylven, C; Esbjornsson-Liljedahl, M; Jansson, E
      Insulin treatment increases skeletal muscle fibre area in patients with diabetes mellitus type 2

      CLINICAL PHYSIOLOGY
    18. Landelius, J; Norinder, U; Svedenhag, J; Nowak, J; Sylven, C
      Beat-to-beat QRS amplitude variability in elite endurance athletes

      CLINICAL PHYSIOLOGY
    19. Eriksson, BE; Sadigh, B; Svedenhag, J; Sylven, C
      Analgesic effects of adenosine in Syndrome X are counteracted by theophylline: a double-blind placebo-controlled study

      CLINICAL SCIENCE
    20. Jensen, J; Eriksson, SV; Lindvall, B; Lundin, P; Sylven, C
      Prognostic role of on-line vectorcardiography as regards repeat revascularization after successful coronary angioplasty

      CARDIOLOGY
    21. Hirschl, MM; Herkner, H; Laggner, AN; Sylven, C; Rasmanis, G; Collinson, PO; Gerhardt, W; Leinberger, R; Zerback, R; Muller-Bardorff, M; Katus, HA
      Analytical and clinical performance of an improved qualitative troponin T rapid test in laboratories and critical care units

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    22. Eriksson, BE; Sylven, C
      Cardiac nociceptive systems

      NERVOUS SYSTEM AND THE HEART
    23. Andersson, B; Blange, I; Sylven, C
      Angiotensin-II type 1 receptor gene polymorphism and long-term survival inpatients with idiopathic congestive heart failure

      EUROPEAN JOURNAL OF HEART FAILURE
    24. Tyni-Lenne, R; Gordon, A; Jensen-Urstad, M; Dencker, K; Jansson, E; Sylven, C
      Aerobic training involving a minor muscle mass shows greater efficiency than training involving a major muscle mass in chronic heart failure patients

      JOURNAL OF CARDIAC FAILURE
    25. Shahrara, S; Drvota, V; Sylven, C
      Organ specific expression of thyroid hormone receptor mRNA and protein in different human tissues

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    26. Tyni-Lenne, R; Jansson, E; Sylven, C
      Female-related skeletal muscle phenotype in patients with moderate chronicheart failure before and after dynamic exercise training

      CARDIOVASCULAR RESEARCH
    27. Shahrara, S; Tidholm, A; Drvota, V; Haggstom, J; Sylven, C
      Upregulation of thyroid hormone receptor beta(1) and beta(2) messenger RNAin the myocardium of dogs with dilated cardiomyopathy or chronic valvular disease

      AMERICAN JOURNAL OF VETERINARY RESEARCH
    28. Dellgren, G; Eriksson, MJ; Blange, I; Brodin, LA; Radegran, K; Sylven, C
      Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operationfor aortic stenosis

      AMERICAN JOURNAL OF CARDIOLOGY
    29. Eriksson, BE; Jansson, E; Kaijser, L; Sylven, C
      Impaired exercise performance but normal skeletal muscle characteristics in female syndrome X patients

      AMERICAN JOURNAL OF CARDIOLOGY
    30. NISELL H; GRUNEWALD C; BERGLUND M; KARLBERG KE; LUNELL NO; SYLVEN C
      PLATELET-AGGREGATION IN-VITRO AND EX-VIVO IN NORMAL-PREGNANCY, PREGNANCY-INDUCED HYPERTENSION, AND PREECLAMPSIA

      Hypertension in pregnancy
    31. KARLBERG KE; SALDEEN T; WALLIN R; HENRIKSSON P; NYQUIST O; SYLVEN C
      INTRAVENOUS NITROGLYCERIN REDUCES ISCHEMIA IN UNSTABLE ANGINA-PECTORIS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY

      Journal of internal medicine
    32. SYLVEN C
      HAPPY POINT IN HEART-FAILURE RESEARCH

      European heart journal
    33. DRVOTA V; BLANGE I; HAGGBLAD J; SYLVEN C
      DESETHYLAMIODARONE PROLONGATION OF CARDIAC REPOLARIZATION IS DEPENDENT ON GENE-EXPRESSION - A NOVEL ANTIARRHYTHMIC MECHANISM

      Journal of cardiovascular pharmacology
    34. NOWAK J; NILSSON T; SYLVEN C; JOGESTRAND T
      POTENTIAL OF CAROTID ULTRASONOGRAPHY IN THE DIAGNOSIS OF CORONARY-ARTERY DISEASE - A COMPARISON WITH EXERCISE TEST AND VARIANCE ECG

      Stroke
    35. BAZZINO O; AYLWARD P; HAINS A; SLANY J; STEINBACH K; VANDEWERF F; VRINTS C; COELHO O; RAMIRES J; BOGATY P; BOUDREAULT J; DIODATI J; GOSSARD D; KOUZ S; LARAMEE P; LEMAY M; MAILLETTE S; THEROUX P; BOTERO R; ARCE M; HEIKKILA J; DANCHIN D; WEBER S; KROMER EP; NEUMANN FJ; NIENABER C; KATRITSIS D; PAPAZAGLOU N; BENHORIN J; DAVID D; TZIVONI D; GUAZZI M; MOGUEL R; VERDEJO J; BONNIER J; DEZWAAN C; HAMER AW; WHITE HD; AARONES M; ARVESEN K; FOSSUM E; HENESTAM B; ROLLAG A; RIBEIRO V; COMMERFORD P; LANDLESS P; MARX J; WEICH H; ANCILLO P; CATURLA J; CIVEIRA E; FERRERO J; FIGUERAS J; GINESTAL R; RUANO M; ERHARDT L; SYLVEN C; LUSCHER T; MOCCETTI T; ADAMS P; ADGEY AAJ; BULLER N; CANEPA R; FURNISS S; GREENBAUM R; HALL J; JENNINGS K; KOONER J; LEVY R; LIPKIN D; NOBLE M; ROTHMAN M; ABRAHAMSON D; AGUIRRE F; AMBROSE J; ANDERSON HV; ANDERSON J; ARORA R; BABB J; BHASIN S; BITTAR N; BOTTI R; BOWLES M; BROWN A; COHEN M; COLFER H; DALEY W; DAWLEY D; DETRANO R; EISENBERG P; FARHAT N; FAXON D; FREY M; FRIEDMAN S; GOLDSCHLAGER N; GRADMAN A; GUTIERREZ F; HATTEMER C; HERRMANN H; HOCHMAN J; ISRAEL N; KIERNAN J; KOREN M; KRAMER J; LING F; MEHTA J; MODY F; MOHIUDDIN S; NAFZIGER A; NAIR R; NIEDERMAN A; PALABRICA T; RODRIGUEZ S; ROSENSON R; RUTHERFORD J; SCHMEDTJE J; SHAH PK; SHARMA S; SMITH S; SMITHERMAN T; STILLABOWER M; TIERSTEIN P; VAUGHAN D; WATERS D; WEINSTOCK P; WILLIAMS M; YAKUBOV S; ZOBLE R; KLEIMAN NS; LIPSCHUTZ KH; SAX FL; CAIRNS J; ESPELAND M; FITZGERALD G; VERSTRAETE M; WEAVER WD; WILLIAMS DO; DREIFUS LS; NASMITH J; RUNGE M; GROSSMAN W; SNAPINN SM; BREMER M; FRAME V; HUTNYAN J; LAPPE JT; SERGIO M; THORNTON A
      A COMPARISON OF ASPIRIN PLUS TIROFIBAN WITH ASPIRIN PLUS HEPARIN FOR UNSTABLE ANGINA

      The New England journal of medicine
    36. MULLERBARDORFF M; WALDENHOFER U; SYLVEN C; COLLINSON PO; GERHARDT W; HAFNER G; ZERBACK R; KATUS HA
      MULTICENTER EVALUATION OF A NEW POINT-OF-CARE SYSTEM FOR THE QUANTITATIVE-DETERMINATION OF TROPONIN-T AND MYOGLOBIN

      Clinical chemistry
    37. TYNILENNE R; JANSSON E; SYLVEN C
      FEMALE-RELATED SKELETAL-MUSCLE PHENOTYPE IN PATIENTS WITH MODERATE CHRONIC HEART-FAILURE BEFORE AND AFTER DYNAMIC EXERCISE TRAINING

      Circulation
    38. TYNILENNE R; GORDON A; JENSENURSTAD M; DENCKER K; JANSSON E; SYLVEN C
      ENDURANCE TRAINING OF MINOR MUSCLE MASS COMPARES WELL WITH TRAINING OF MAJOR MUSCLE MASS ON CYCLE ERGOMETER IN CHRONIC HEART-FAILURE PATIENTS

      Circulation
    39. Shahrara, S; Drvota, V; Blange, I; Torma, H; Sylven, C
      Characterization of AT-1 cardiomyocytes as a model for studies of T-3 effects on cardiac cells (vol 237, pg 303, 1997)

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    40. SYLVEN C; LINDAHL S; NYQUIST O; RASMANIS G
      EXCELLENT RELIABILITY OF NURSE-BASED BEDSIDE DIAGNOSIS OF ACUTE MYOCARDIAL-INFARCTION BY RAPID DRY-STRIP CREATINE-KINASE MB, MYOGLOBIN, ANDTROPONIN-T

      The American heart journal
    41. BJORCK S; BLOHME G; SYLVEN C; MULEC H
      DELETION INSERTION POLYMORPHISM OF THE ANGIOTENSIN-CONVERTING ENZYME GENE AND PROGRESSION OF DIABETIC NEPHROPATHY

      Nephrology, dialysis, transplantation
    42. BLANGE I; DRVOTA V; YEN PM; SYLVEN C
      SPECIES-DIFFERENCES IN CARDIAC THYROID-HORMONE RECEPTOR ISOFORMS PROTEIN ABUNDANCE

      Biological & pharmaceutical bulletin
    43. BLANGE I; DRVOTA V; SYLVEN C
      SPECIES-DIFFERENCES IN CARDIAC THYROID-HORMONE RECEPTOR ISOFORMS PROTEIN ABUNDANCE

      The FASEB journal
    44. KARLSSON J; LIN LJ; GUNNES S; SYLVEN C; ASTROM H; JANSSON E; SEMB B
      MUSCLE CHARACTERISTICS IN EFFORT ANGINA BEFORE AND AFTER CABG

      Canadian journal of cardiology
    45. TIDHOLM A; SVENSSON H; SYLVEN C
      SURVIVAL AND PROGNOSTIC FACTORS IN 189 DOGS WITH DILATED CARDIOMYOPATHY

      The Journal of the American Animal Hospital Association
    46. SYLVEN C
      NEUROPHYSIOLOGICAL ASPECTS OF ANGINA-PECTORIS

      Zeitschrift fur Kardiologie
    47. GERHARDT W; LJUNGDAHL L; COLLINSON PO; LOVIS C; MACH F; SYLVEN C; RASMANIS G; LEINBERGER R; ZERBACK R; MULLERBARDORFF M; KATUS HA
      AN IMPROVED RAPID TROPONIN-T TEST WITH A DECREASED DETECTION LIMIT - A MULTICENTER STUDY OF THE ANALYTICAL AND CLINICAL-PERFORMANCE IN SUSPECTED MYOCARDIAL DAMAGE

      Scandinavian journal of clinical & laboratory investigation
    48. ANDERSSON B; BLANGE I; SYLVEN C
      THE INTERACTION BETWEEN POLYMORPHISMS OF THE ANGIOTENSIN RECEPTOR GENE AND THE ACE GENE ON LONG-TERM MORTALITY IN CONGESTIVE-HEART-FAILURE

      Circulation
    49. MAGNUSSON G; KAIJSER L; SYLVEN C; KARLBERG KE; ISBERG B; SALTIN B
      PEAK SKELETAL-MUSCLE PERFUSION IS MAINTAINED IN PATIENTS WITH CHRONICHEART-FAILURE WHEN ONLY A SMALL MUSCLE MASS IS EXERCISED

      Cardiovascular Research
    50. SHAHRARA S; DRVOTA V; BLANGE I; TORMA H; SYLVEN C
      CHARACTERIZATION OF AT-1 CARDIOMYOCYTES AS A MODEL FOR STUDIES OF T-3EFFECTS ON CARDIAC-CELLS

      Biochemical and biophysical research communications
    51. TYNILENNE R; GORDON A; JANSSON E; BERMANN G; SYLVEN C
      SKELETAL-MUSCLE ENDURANCE TRAINING IMPROVES PERIPHERAL OXIDATIVE CAPACITY, EXERCISE TOLERANCE, AND HEALTH-RELATED QUALITY-OF-LIFE IN WOMEN WITH CHRONIC CONGESTIVE-HEART-FAILURE SECONDARY TO EITHER ISCHEMIC CARDIOMYOPATHY OR IDIOPATHIC DILATED CARDIOMYOPATHY

      The American journal of cardiology
    52. MATTSSON E; MARTINSSON A; NYQVIST O; RASMANIS G; SYLVEN C; KARLBERG KE
      THE GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR BLOCKER TIROFIBAN NOT HEPARIN, COUNTERACTS PLATELET-AGGREGATION IN UNSTABLE ANGINA-PECTORIS/

      The American journal of cardiology
    53. JONZON B; KARLBERG KE; QUERROLFERRER V; SYLVEN C
      EFFECTS OF ADENOSINE ON EX-VIVO FILTRAGOMETRY PLATELET-AGGREGATION INRELATION TO PLASMA-LEVELS

      Acta Physiologica Scandinavica
    54. HELLSTROM G; MAGNUSSON G; WAHLGREN NG; GORDON A; SYLVEN C; SALTIN B
      PHYSICAL EXERCISE MAY IMPAIR CEREBRAL PERFUSION IN PATIENTS WITH CHRONIC HEART-FAILURE

      Cardiology in the elderly
    55. SYLVEN C; ERIKSSON B; JENSEN J; GEIGANT E; HALLIN RG
      ANALGESIC EFFECTS OF ADENOSINE DURING EXERCISE-PROVOKED MYOCARDIAL-ISCHEMIA

      NeuroReport
    56. SYLVEN C; ERIKSSON B; SHEPS DS; MAIXNER B
      BETA-ENDORPHIN BUT NOT MET-ENKEPHALIN COUNTERACTS ADENOSINE-PROVOKED ANGINA PECTORIS-LIKE PAIN

      NeuroReport
    57. ANDERSSON B; SYLVEN C
      THE DD GENOTYPE OF THE ANGIOTENSIN-CONVERTING ENZYME GENE IS ASSOCIATED WITH INCREASED MORTALITY IN IDIOPATHIC HEART-FAILURE

      Journal of the American College of Cardiology
    58. LILJEDAHL ME; HOLM I; SYLVEN C; JANSSON E
      DIFFERENT RESPONSES OF SKELETAL-MUSCLE FOLLOWING SPRINT TRAINING IN MEN AND WOMEN

      European journal of applied physiology and occupational physiology
    59. KARLSSON J; LIN LJ; SYLVEN C; JANSSON E
      MUSCLE UBIQUINONE IN HEALTHY PHYSICALLY ACTIVE MALES

      Molecular and cellular biochemistry
    60. KARLSSON J; LIN LJ; GUNNES S; SYLVEN C; ASTROM H
      MUSCLE UBIQUINONE IN MALE EFFORT ANGINA PATIENTS

      Molecular and cellular biochemistry
    61. MAGNUSSON G; GORDON A; KAIJSER L; SYLVEN C; ISBERG B; KARPAKKA J; SALTIN B
      HIGH-INTENSITY KNEE EXTENSOR TRAINING, IN PATIENTS WITH CHRONIC HEART-FAILURE - MAJOR SKELETAL-MUSCLE IMPROVEMENT

      European heart journal
    62. GORDON A; TYNILENNE R; PERSSON H; KAUSER L; HULTMAN E; SYLVEN C
      MARKEDLY IMPROVED SKELETAL-MUSCLE FUNCTION WITH LOCAL MUSCLE TRAININGIN PATIENTS WITH CHRONIC HEART-FAILURE

      Clinical cardiology
    63. MAGNUSSON G; KAIJSER L; RONG H; ISBERG B; SYLVEN C; SALTIN B
      EXERCISE CAPACITY IN HEART-FAILURE PATIENTS - RELATIVE IMPORTANCE OF HEART AND SKELETAL-MUSCLE

      Clinical physiology
    64. SYLVEN C; JANSSON E; SOTONYI P; WAAGSTEIN F; BARKHEM T; BRONNEGARD M
      CARDIAC NUCLEAR HORMONE-RECEPTOR MESSENGER-RNA IN HEART-FAILURE IN MAN

      Life sciences
    65. DELLGREN G; ERIKSSON M; BLANGE I; BRODIN LA; RADEGRAN K; SYLVEN C
      THE DD GENOTYPE OF THE ACE-GENE ACCENTUATES LEFT-VENTRICULAR HYPERTROPHY IN PATIENTS WITH AORTIC-STENOSIS

      Circulation
    66. GORDON A; HELLSTROM G; MAGNUSSON G; WAHLGREN NG; SALTIN B; SYLVEN C
      IMPAIRED CEREBRAL BLOOD-FLOW DURING PHYSICAL EXERCISE IN PATIENTS WITH MODERATE CHRONIC HEART-FAILURE

      Circulation
    67. SYLVEN C; ERIKSSON B; JENSEN J; GEIGANT E; HALLIN RG; JOELSSON V
      ANALGESIC EFFECTS OF ADENOSINE DURING EXERCISE PROVOKED MYOCARDIAL-ISCHEMIA IS NOT DUE TO PRECONDITIONING - A DOUBLE-BLIND PLACEBO-CONTROLLED CROSSOVER STUDY

      Circulation
    68. HAGERMAN I; BERGLUND M; LORIN M; NOWAK J; SYLVEN C
      CHAOS-RELATED DETERMINISTIC REGULATION OF HEART-RATE-VARIABILITY IN TIME AND FREQUENCY DOMAINS - EFFECTS OF AUTONOMIC BLOCKADE AND EXERCISE

      Cardiovascular Research
    69. HAGERMAN I; NOWAK J; SVEDENHAG J; NYQUIST O; SYLVEN C
      BEAT-TO-BEAT QRS AMPLITUDE VARIABILITY DURING DOBUTAMINE INFUSION IN PATIENTS WITH CORONARY-ARTERY DISEASE

      Cardiology
    70. HAGERMAN I; BERGLUND M; SVEDENHAG J; NOWAK J; SYLVEN C
      BEAT-TO-BEAT QRS AMPLITUDE VARIABILITY AFTER ACUTE MYOCARDIAL-INFARCTION AND CORONARY-ARTERY BYPASS-GRAFTING

      The American journal of cardiology
    71. NOWAK J; ANDERSSON K; BENTHIN G; CHEN J; KARLBERG KE; SYLVEN C
      EFFECT OF NICOTINE INFUSION IN HUMANS ON PLATELET-AGGREGATION AND URINARY-EXCRETION OF A MAJOR THROMBOXANE METABOLITE

      Acta Physiologica Scandinavica
    72. SYLVEN C; JANSSON E; SOTONYI P; WAAGSTEIN F; BRONNEGARD M
      NA,K-ATPASE RECEPTOR SUBUNITS ALPHA-1, ALPHA-2 AND ALPHA-3 MESSENGER-RNA IN DILATED CARDIOMYOPATHY

      Biological & pharmaceutical bulletin
    73. SYLVEN C; MISCHA G; JANSSON E; SOTONYI P; FU LX; WAAGSTEIN F; BRONNEGARD M
      BETA-1 AND BETA-2 ADRENOCEPTOR LIGAND AND MESSENGER-RNA EXPRESSION INDILATED CARDIOMYOPATHY

      Biological & pharmaceutical bulletin
    74. HUANG MH; SYLVEN C; HORACKOVA M; ARMOUR JA
      VENTRICULAR SENSORY NEURONS IN CANINE DORSAL-ROOT GANGLIA - EFFECTS OF ADENOSINE AND SUBSTANCE-P

      American journal of physiology. Regulatory, integrative and comparative physiology
    75. SYLVEN C; HAGERMAN I; KARLBERG KE; CHEN J; WALLIN R; ENEROTH P; BERGSTROM K; SALDEEN T
      PLATELET AND LEUKOCYTE ACTIVATION AFTER MYOCARDIAL-INFARCTION - INFLUENCE OF ENALAPRIL

      European heart journal
    76. DRVOTA V; CARLSSON B; HAGGBLAD J; SYLVEN C
      AMIODARONE IS A DOSE-DEPENDENT NONCOMPETITIVE AND COMPETITIVE INHIBITOR OF T3 BINDING TO THYROID-HORMONE RECEPTOR SUBTYPE BETA-1, WHEREAS DISOPYRAMIDE, LIGNOCAINE, PROPAFENONE, METOPROLOL, DL-SOTALOL, AND VERAPAMIL HAVE NO INHIBITORY EFFECT

      Journal of cardiovascular pharmacology
    77. VIIDAS U; NOREE LO; AHLMEN J; THEODORSSON E; SYLVEN C
      AMBULATORY 24-HOUR BLOOD-PRESSURE AND PEPTIDE IN HEMODIALYSIS-PATIENTS BALANCE

      Scandinavian journal of urology and nephrology
    78. DRVOTA V; BRONNEGARD M; HAGGBLAD J; SYLVEN C
      DOWN-REGULATION OF THYROID-HORMONE RECEPTOR SUBTYPE MESSENGER-RNA LEVELS BY AMIODARONE DURING CATECHOLAMINE STRESS IN-VITRO

      Circulation
    79. GORDON A; HULTMAN E; KAIJSER L; KRISTJANSSON S; ROLF CJ; NYQUIST O; SYLVEN C
      CREATINE SUPPLEMENTATION IN CHRONIC HEART-FAILURE INCREASES SKELETAL-MUSCLE CREATINE-PHOSPHATE AND MUSCLE PERFORMANCE

      Cardiovascular Research
    80. DRVOTA V; BRONNEGARD M; HAGGBLAD J; BARKHEM T; SYLVEN C
      DOWN-REGULATION OF THYROID-HORMONE RECEPTOR SUBTYPE MESSENGER-RNA LEVELS BY AMIODARONE DURING CATECHOLAMINE STRESS IN-VITRO

      Biochemical and biophysical research communications
    81. DRVOTA V; JANSON A; NORMAN C; SYLVEN C; HAGGBLAD J; BRONNEGARD M; MARCUS C
      EVIDENCE FOR THE PRESENCE OF FUNCTIONAL THYROTROPIN RECEPTOR IN CARDIAC-MUSCLE

      Biochemical and biophysical research communications
    82. DRVOTA V; WEI H; HAGGBLAD J; CARLSSON B; SYLVEN C
      BETA-ADRENERGIC-RECEPTOR FUNCTION IN CULTURED AT-1 CARDIOMYOCYTES

      Biochemical and biophysical research communications
    83. ERIKSSON B; SVEDENHAG J; MARTINSSON A; SYLVEN C
      EFFECTS OF EPINEPHRINE INFUSION ON CHEST PAIN IN SYNDROME-X IN THE ABSENCE OF SIGNS OF MYOCARDIAL-ISCHEMIA

      The American journal of cardiology
    84. ERIKSSON B; VUORISALO D; SYLVEN C
      DIAGNOSTIC POTENTIAL OF CHEST PAIN CHARACTERISTICS IN CORONARY-CARE

      Journal of internal medicine
    85. HAGEMAN I; NOWAK J; NYQUIST O; SVEDENHAG J; SYLVEN C
      DOBUTAMINE-PROVOKED MYOCARDIAL-ISCHEMIA INCREASES BEAT-TO-BEAT QRS AMPLITUDE VARIABILITY IN PATIENTS WITH CORONARY-ARTERY DISEASE

      Journal of the American College of Cardiology
    86. GORDON A; KAIJSER L; MAGNUSSON G; SALTIN B; SYLVEN C
      IMPROVED PHYSICAL PERFORMANCE IN CONGESTIVE-HEART-FAILURE (CHF) BY ONE-LEG ENDURANCE COMPARED TO ONE-LEG STRENGTH TRAINING

      Journal of the American College of Cardiology
    87. SYLVEN C; HAGERMAN I; YLEN M; NYQUIST O; NOWAK J
      VARIANCE ECG DETECTION OF CORONARY-ARTERY DISEASE - A COMPARISON WITHEXERCISE STRESS TEST AND MYOCARDIAL SCINTIGRAPHY

      Clinical cardiology
    88. FREYSCHUSS U; HJELTE L; JOHANNESSON M; NOWAK J; SYLVEN C
      SIGNAL VARIANCE ELECTROCARDIOGRAM - A TEST FOR EARLY DETECTION OF MYOCARDIAL INVOLVEMENT IN CYSTIC-FIBROSIS

      Clinical science
    89. BRONNEGARD M; TORRING O; BOOS J; SYLVEN C; MARCUS C; WALLIN G
      EXPRESSION OF THYROTROPIN RECEPTOR AND THYROID-HORMONE RECEPTOR MESSENGER-RIBONUCLEIC-ACID IN NORMAL, HYPERPLASTIC, AND NEOPLASTIC HUMAN THYROID-TISSUE

      The Journal of clinical endocrinology and metabolism
    90. DRVOTA V; CARLSSON B; HAGGBLAD J; SYLVEN C
      AMIODARONE IS A DOSE-DEPENDENT COMPETITIVE AND NONCOMPETITIVE INHIBITOR OF T3 BINDING TO HUMAN THYROID-HORMONE RECEPTOR-BETA-1 WHEREAS DISOPYRAMIDE, LIGNOCAINE, PROPAFENONE, METOPROLOL, SOTALOL AND VERAPAMIL HAVE NO EFFECT

      Circulation
    91. DRVOTA V; CARLSSON B; HAGGBLAD J; SYLVEN C
      AMIODARONE IS A DOSE-DEPENDENT COMPETITIVE AND NONCOMPETITIVE INHIBITOR OF T3 BINDING TO HUMAN THYROID-HORMONE RECEPTOR-BETA-1 WHEREAS DISOPYRAMIDE, LIGNOCAINE, PROPAFENONE, METOPROLOL, SOTALOL AND VERAPAMIL HAVE NO EFFECT

      Circulation
    92. HUANG MH; SYLVEN C; PELLEG A; ARMOUR JA
      RESPONSIVENESS OF CANINE NODOSE GANGLION TO CARDIAC MECHANICAL AND ORCHEMICAL STIMULI AND TRANSIENT MYOCARDIAL-ISCHEMIA

      Circulation
    93. HUANG MH; SYLVEN C; PELLEG A; ARMOUR JA
      RESPONSIVENESS OF CANINE NODOSE GANGLION TO CARDIAC MECHANICAL AND ORCHEMICAL STIMULI AND TRANSIENT MYOCARDIAL-ISCHEMIA

      Circulation
    94. GORDON A; HULTMAN E; KAIJSER L; MARE C; JOHANSSON C; NYQUIST O; SYLVEN C
      CREATINE SUPPLEMENTATION IN HEART-FAILURE INCREASES SKELETAL-MUSCLE CREATINE-PHOSPHATE AND MUSCLE PERFORMANCE

      Circulation
    95. GORDON A; HULTMAN E; KAIJSER L; MARE C; JOHANSSON C; NYQUIST O; SYLVEN C
      CREATINE SUPPLEMENTATION IN HEART-FAILURE INCREASES SKELETAL-MUSCLE CREATINE-PHOSPHATE AND MUSCLE PERFORMANCE

      Circulation
    96. ARMOUR JA; HUANG MH; PELLEG A; SYLVEN C
      RESPONSIVENESS OF IN-SITU CANINE NODOSE GANGLION AFFERENT NEURONS TO EPICARDIAL MECHANICAL OR CHEMICAL STIMULI

      Cardiovascular Research
    97. MAGNUSSON G; ISBERG B; KARLBERG KE; SYLVEN C
      SKELETAL-MUSCLE STRENGTH AND ENDURANCE IN CHRONIC CONGESTIVE-HEART-FAILURE SECONDARY TO IDIOPATHIC DILATED CARDIOMYOPATHY

      The American journal of cardiology
    98. KARLBERG KE; NOWAK J; AHLNER J; SYLVEN C
      EVIDENCE FOR TOLERANCE TO THE PLATELET INHIBITORY EFFECT OF NITROGLYCERIN

      The American journal of cardiology
    99. KARLBERG KE; CHEN J; HAGERMAN I; BERGSTROM K; WALLIN R; SALDEEN T; SYLVEN C
      STREPTOKINASE, BUT NOT TISSUE-PLASMINOGEN ACTIVATOR, ATTENUATES PLATELET-AGGREGATION IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

      Journal of internal medicine
    100. SYLVEN C
      SYNDROME-X

      Journal of internal medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 22:45:17